David Buck analyst

Currently out of the existing stock ratings of David Buck, 37 are a BUY (80.43%), 9 are a HOLD (19.57%).

David Buck

Work Performance Price Targets & Ratings Chart

Analyst David Buck, has had 53.93% of price targets met with an average potential upside of 26.55%, reached in 401 days on average. Previously, David Buck worked at B. RILEY, NORTHLAND CAPITAL MARKETS.

David Buck has documented 90 price targets and ratings displayed on 9 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on CORT, Corcept Therapeutics at 04-Feb-2019.

Wall Street Analyst David Buck

Analyst best performing recommendations are on ENDP (ENDO INTERNATIONAL PLC).
The best stock recommendation documented was for ENDP (ENDO INTERNATIONAL PLC) on 8/7/2018. The price target of $15 was fulfilled within 1 day with a profit of $2.35 (18.58%), with a performance score of 185.77.

Average potential price target upside

JAZZ Jazz Pharmaceuticals PLC MNK Mallinckrodt plc AMAG AMAG Pharmaceuticals SPPI Spectrum Pharmaceuticals SUPN Supernus Pharmaceuticals ALKS Alkermes Plc CORT Corcept Therapeutics ENDP Endo International PLC PRGO Perrigo Company PLC

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 06-Mar-2025

$324

$93.74 (40.71%)

$319

8 days ago
(12-Nov-2026)

19/25 (76%)

$82.45 (34.13%)

428

Buy Since 23-Feb-2021

$330

$99.74 (43.32%)

$310

9 days ago
(11-Nov-2026)

39/42 (92.86%)

$89.63 (37.29%)

1356

Buy Since 10-Mar-2016

$310

$79.74 (34.63%)

$300

18 days ago
(02-Nov-2026)

20/23 (86.96%)

$80.26 (34.94%)

1608

Buy Since 07-Jul-2025

$305

$74.74 (32.46%)

$296

18 days ago
(02-Nov-2026)

8/10 (80%)

$75.26 (32.76%)

68

Buy Since 26-Feb-2026

$275

$44.74 (19.43%)

$271

18 days ago
(02-Nov-2026)

6/9 (66.67%)

$45.26 (19.70%)

39

Show more analysts

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?